Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.675
Bid: 1.65
Ask: 1.70
Change: 0.025 (1.52%)
Spread: 0.05 (3.03%)
Open: 1.65
High: 1.95
Low: 1.65
Prev. Close: 1.65
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

Fri, 03rd Feb 2023 10:26

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

88 Energy Ltd, up 17% at 0.69 pence, 12-month range 0.40p-2.82p. The Alaska-focused oil explorer on recovers after a 9.1% share price fall on Thursday. On Thursday, it said it plans to raise up to AUD12.0 million, about GBP6.8 million, through a placing. The company said it also has the ability to accept over-subscriptions to increase the total amount raised to up to AUD15.0 million. The shares are priced at AUD0.0095, which represents a 21% discount to the shares closing priced on the Australian Securities Exchange on Wednesday. The company says the proceeds will be used to fund the planned Hickory-1 well at Project Phoenix, payment for the new Project Leonis acreage, and finance potential portfolio expansion.

----------

Genedrive PLC, up 13% at 24.32p, 12-month range 8.00p-42.00p. The Manchester-based molecular diagnostics company continues to surge after strong start to 2023. Since the start of the year, the company's shares are up 99%, over the past 12-months stock is up 13%.

----------

AIM - LOSERS

----------

Petro Matad Ltd, down 33% at 2.74p, 12-month range 1.60p-5.60p. On Thursday, the petroleum exploration company focused on Mongolia said it plans to raise GBP500,000 through a retail offer by way of an accelerated bookbuild process at an issue price of 2.5 pence per retail offer share. Petro noted that the retail offer is conditional on the capital-raising shares being admitted to trading on AIM.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Apr 2020 14:47

Inspiration Healthcare Signs Distribution Agreement With Genedrive

Inspiration Healthcare Signs Distribution Agreement With Genedrive

Read more
20 Apr 2020 11:40

Genedrive To Collaborate On Rapidly Manufactured Covid-19 Test

Genedrive To Collaborate On Rapidly Manufactured Covid-19 Test

Read more
25 Mar 2020 14:57

Genedrive Shares Soar As It Says It Will Develop SARS-COV-2 Tests

Genedrive Shares Soar As It Says It Will Develop SARS-COV-2 Tests

Read more
4 Feb 2020 12:22

Genedrive Shares Plunge 45% As Loss Widens On Shipping Order Delays

Genedrive Shares Plunge 45% As Loss Widens On Shipping Order Delays

Read more
28 Jan 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Dec 2019 10:10

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Read more
3 Dec 2019 09:39

Genedrive upbeat on latest results from RNR1 kit testing

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.

Read more
18 Nov 2019 16:00

Genedrive infant hearing loss test gets CE mark

(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.

Read more
18 Nov 2019 11:15

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Read more
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.